利美达松局部治疗淋巴性甲状腺炎观察  

Effect of Local Injcetion of Limethason in the Treatment of Chronic Lymphocytic Thyroiditis

作　　者：陈树[1] 杨秀川[2] 李蓬秋[2] 王思琴[2] 王浩然[2] 吕月婵[2] 曾秀华[2] 

机构地区：[1]四川省人民医院科技处 [2]四川省人民医院内科

出　　处：《医学科技》1994年第28期6-8,共3页

摘　　要：本文报告采用日本株氏会社绿十字生产的利美达松(氟美松棕榈酸酯制剂)局部注射治疗淋巴性甲状腺炎伴甲状腺Ⅱ°以上肿大的女性患者12例,并与口服强的松治疗组8例对照,以观察该方法及药物对淋巴性甲状腺炎患者的疗效。结果显示:利美达松局部注射治疗的患者,治疗效果及体征好转时间优于对照组。临床副作用明显较少,血中免疫指标紊乱也得到纠正,病员依从性好,无不良反应,可以在临床应用。Twelve female patients with chronic lymphocytic thyroiditis were treated withlocal injection of limethason (japan Green Cnoss CO. Lld)Eight patients were used ascontrols treated with oral administration of prednison. The results showed thatlimethason was more effective than prednison in the reduction of Goitre and otherside effects, the improvement of immunoloical disorders and easy to be accepted bythe patients. Therefore as a long-effective agent, Limethason is available in thetreatment of chronic lymphocytic thyroiditis.

关 键 词：淋巴性 甲状腺炎 利美达松 局部治疗 

分 类 号：R581.405[医药卫生—内分泌] R977.14[医药卫生—内科学]